GlassScriptPhysician profile
Kaitlin Mae Corbett
NPI 1205432416
$2,775.48
in general payments reported to CMS, 2019-2025
34 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,440 · 2022: $727 · 2023: $325 · 2024: $153 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $540 · Travel and Lodging: $69.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $539.53 |
| Travel and Lodging | $69.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $532.59 | 2023-2025 | Menopur |
| Emd Serono, INC. | $242.41 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $142.51 | 2021-2022 | |
| Biogen, INC. | $136.63 | 2021-2022 | |
| Genzyme Corporation | $124.99 | 2021 | |
| Novartis Pharmaceuticals Corporation | $124.14 | 2021-2022 | |
| Mdd US Operations, LLC | $123.98 | 2021-2022 | |
| Ucb, INC. | $117.60 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $105.89 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $94.57 | 2021-2022 | |
| Eisai INC. | $89.53 | 2021 | |
| Harmony Biosciences LLC | $81.72 | 2021 | |
| Ge Healthcare | $80.19 | 2021 | |
| Amgen INC. | $78.31 | 2021-2022 | |
| Abbvie INC. | $74.31 | 2022-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $68.31 | 2021 | |
| Neurocrine Biosciences, INC. | $54.28 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.87 | 2022 | |
| Sk Life Science, INC. | $49.60 | 2021 | |
| Sunovion Pharmaceuticals INC. | $48.74 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $48.64 | 2021-2022 | |
| Tanabe Pharma America, INC. | $38.14 | 2021 | |
| Lilly USA, LLC | $37.79 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $29.24 | 2022 | |
| Acorda Therapeutics, INC | $27.68 | 2021 | |
| Avion Pharmaceuticals | $27.03 | 2022 | |
| Grifols USA, LLC | $24.72 | 2022 | |
| Amneal Pharmaceuticals LLC | $22.24 | 2022 | |
| Avanir Pharmaceuticals, INC. | $20.62 | 2021 | |
| Allergan, INC. | $19.70 | 2021 | |
| Csl Behring | $17.08 | 2022 | |
| Kyowa Kirin, INC. | $16.64 | 2021 | |
| Supernus Pharmaceuticals, INC. | $13.32 | 2022 | |
| Acadia Pharmaceuticals INC | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Corbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.